Potassium-chloride cotransporter 3 interacts with Vav2 to synchronize the cell volume decrease response with cell...

Area of Science:

• Molecular Biology
• Cell Biology
• Neuroscience

Background:

• Loss-of-function mutations in potassium-chloride cotransporter 3 (KCC3) cause hereditary motor and sensory neuropathy with agenesis of the corpus callosum (HMSN/ACC).
• KCC3 overexpression correlates with increased malignancy and invasiveness in breast, ovarian, and cervical cancers.

Purpose of the Study:

• To investigate the molecular mechanisms underlying KCC3 function in cell volume regulation and its role in cancer and neurological disorders.
• To identify proteins interacting with KCC3 and elucidate their functional significance.

Main Methods:

• Site-directed mutagenesis of a proline-rich C-terminal motif in KCC3.
• Assessing KCC3-dependent regulatory volume decrease (RVD) in Xenopus laevis oocytes.
• SH3 domain array screening to identify interacting proteins.
• GST-pull down assays and co-immunoprecipitation to confirm KCC3-Vav2 interaction.
• Immunofluorescence microscopy in cultured cervical cancer cells to determine subcellular localization of KCC3 and active Vav2.

Main Results:

• A mutation in the KCC3 C-terminal proline-rich region abolished the KCC3-dependent RVD response.
• SH3 domain array identified Vav2, a guanine nucleotide exchange factor (GEF), as a KCC3-interacting protein.
• KCC3 physically interacts with Vav2.
• KCC3 and active Vav2 co-localize in actin-rich structures, including lamellipodia, during cell spreading and migration in cervical cancer cells.

Conclusions:

• KCC3 interacts with the Rho GTPase-dependent actin remodeling machinery via Vav2.
• This interaction is crucial for regulatory volume decrease, cell spreading, and cell protrusion dynamics.
• These findings provide novel insights into KCC3's role in cancer cell malignancy and the pathogenesis of HMSN/ACC.